Background: Qualitative alterations of lipoproteins underlie the high incidence of atherosclerosis in diabetes. The objective of this study was to assess the impact of low-density lipoprotein (LDL) subfraction phenotype on the qualitative characteristics of LDL and high-density lipoprotein (HDL) in patients with type 2 diabetes.

Methods: One hundred twenty two patients with type 2 diabetes in poor glycemic control and 54 healthy subjects were included in the study. Patients were classified according to their LDL subfraction phenotype. Seventy-seven patients presented phenotype A whereas 45 had phenotype B. All control subjects showed phenotype A. Several forms of modified LDL, HDL composition and the activity and distribution of lipoprotein-associated phospholipase A2 (Lp-PLA2) were analyzed.

Results: Oxidized LDL, glycated LDL and electronegative LDL were increased in both groups of patients compared with the control group. Patients with phenotype B had increased oxidized LDL and glycated LDL concentration than patients with phenotype A. HDL composition was abnormal in patients with diabetes, being these abnormalities more marked in patients with phenotype B. Total Lp-PLA2 activity was higher in phenotype B than in phenotype A or in control subjects. The distribution of Lp-PLA2 between HDL and apoB-containing lipoproteins differed in patients with phenotype A and phenotype B, with higher activity associated to apoB-containing lipoproteins in the latter.

Conclusions: The presence of LDL subfraction phenotype B is associated with increased oxidized LDL, glycated LDL and Lp-PLA2 activity associated to apoB-containing lipoproteins, as well as with abnormal HDL composition.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750253PMC
http://dx.doi.org/10.1186/1475-2840-12-112DOI Listing

Publication Analysis

Top Keywords

ldl subfraction
16
subfraction phenotype
16
hdl composition
16
patients phenotype
16
phenotype
14
ldl
13
phenotype phenotype
12
oxidized ldl
12
ldl glycated
12
glycated ldl
12

Similar Publications

Low-density lipoprotein (LDL) cholesterol (chol) subfractions are risk biomarkers for cardiovascular diseases (CVD). A reference analysis, ultracentrifugation (UC), is laborious and may be replaced with a rapid prediction using proton NMR spectra of human blood plasma. However, the quality and uniqueness of these prediction models of biologically related subfractions remains unknown.

View Article and Find Full Text PDF

Variance in the composition and number of VLDL and LDL particles with increasing triglyceride or increasing ApoB concentrations.

J Clin Lipidol

October 2024

Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre, Room H7.22, Royal Victoria Hospital, 687 Pine Avenue West, Montreal, Quebec H3A 1A1, Canada.

Objective: The importance of any enhanced atherogenicity of triglyceride (TG)-rich lipoproteins (TRLs) will depend on the relative abundance of these particles compared with LDL or total apolipoprotein (apo)B. Accordingly, we determined the contribution that TRLs make to total apoB as TG or apoB concentrations increase. We also describe compositional changes in TRLs as TG or apoB increase to assess whether VLDL-C is a valid proxy for VLDL-apoB.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with type 2 diabetes mellitus (T2DM) show a higher risk of cognitive impairment, prompting a study on the effects of a specific LDL-C subfraction called L5 on their cognitive function.
  • The study involved 68 T2DM patients, examining their cognitive abilities and using a new analysis method, HHSA, to assess the impact of L5 on neural activity.
  • Results indicated that higher L5 levels are linked to increased risks of mild cognitive impairment (MCI) and Alzheimer’s disease, with a negative correlation between L5 and cognitive performance, particularly in MCI patients, suggesting L5 could serve as a useful biomarker for cognitive decline in T2DM.
View Article and Find Full Text PDF

Clinical trial results indicate that statin therapy aimed at normalising the lipid profile can prevent and reduce the risk of cardiovascular events. Both LDL and HDL consist of several subfractions, with only the smallest and densest subfractions being the most atherogenic. We examine the effect of Atorvastatin treatment not only on basic lipid profile parameters but also atherogenic lipoprotein subfractions and 25(OH)D levels in patients after the first acute myocardial infarction.

View Article and Find Full Text PDF

Lipoprotein (Sub)Fraction Analysis on the Bruker B.I. LISA Platform.

Methods Mol Biol

October 2024

Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.

The Bruker B.I. LISA platform provides a method for human plasma/serum lipoprotein analysis and yields data on the particle numbers and lipids of the main lipoprotein classes (VLDL, IDL, LDL, HDL), and the subfractions within those classes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!